NCT07943702
Correlation Between Visual Reading and DOlab Software Quantitative Analysis of DaT-SPECT Images
StatusRecruiting
PhaseNot specified
SponsorDorian Technologies S.r.l.
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Correlation between visual score and DOlab quantitative metrics
Timeframe: Phase 1 reading session, within 4 months of study start
Secondary (3)
Agreement between visual and software-supported semi-quantitative classification
Number of scans reclassified with software support
Software usability (System Usability Scale)
Arms and interventions
Adults referred for DaT-SPECT
Adults referred for evaluation of nigrostriatal dopaminergic dysfunction at the two participating centers between January 2015 and May 2025, whose existing 123I-ioflupane DaT-SPECT scans were selected retrospectively (30 per visual grade 0-3, 15 per grade per center). Each scan is read visually by four blinded readers, analyzed by DOlab software, and then re-read with the software report.
Devices: DOlab software - DaT-SPECT workflow
Diagnostic tests: Visual interpretation (comparator)
Sites
2 sites in 1 country